MedPath

China Academy of Chinese Medical Sciences

🇨🇳China
Ownership
-
Established
1955-01-01
Employees
-
Market Cap
-
Website
http://www.cacms.ac.cn/

Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis

Not Applicable
Conditions
Efficiency of Genuine Regional and Non-genuine Regional Rhizoma Atractylodis in Treating FD
Interventions
Drug: genuine regional Rhizoma Atractylodis (Maozhu granule)
First Posted Date
2017-06-01
Last Posted Date
2017-06-01
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
90
Registration Number
NCT03173183

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection

Phase 4
Conditions
Angina
Interventions
Drug: Salvianolate injection
First Posted Date
2016-03-01
Last Posted Date
2016-03-01
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
120
Registration Number
NCT02694848
Locations
🇨🇳

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Phase 4
Conditions
Acute Upper Respiratory Infection
Interventions
Drug: Jinyebaidu granule
Drug: Fufangshuanghua granule
Drug: Fufangshuanghua granule placebo
Drug: Jinyebaidu granule placebo
First Posted Date
2015-09-03
Last Posted Date
2015-09-03
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
600
Registration Number
NCT02539277
Locations
🇨🇳

Guang'anmen Hospital, Beijing, Beijing, China

Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
Other: individualized treatment
First Posted Date
2015-03-31
Last Posted Date
2015-03-31
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
600
Registration Number
NCT02402959
Locations
🇨🇳

Guang'anmen Hospital of China Academy of China Medical Sciences, Beijing, Beijing, China

🇨🇳

East Hospital of Beijing University of Traditional Chinese Medicine, Beijing, Beijing, China

🇨🇳

Fujian Institute of Traditional Chinese Medicine, Fuzhou, Fujian, China

and more 4 locations

Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke

Phase 4
Completed
Conditions
Acute Stroke
Interventions
Drug: Danhong injection
Procedure: Standard medical care
Drug: placebo
First Posted Date
2014-06-27
Last Posted Date
2020-07-15
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
46
Registration Number
NCT02176395
Locations
🇨🇳

Panjin Central Hospital, Panjin, Liaoning, China

🇨🇳

202 Military Hospital of China, Shenyang, Liaoning, China

🇨🇳

Nanshi Hospital of Nanyang, Nanyang, Henan, China

and more 1 locations

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

Phase 4
Completed
Conditions
Dyslipidemia
Interventions
Drug: Xuezhikang capsule
First Posted Date
2014-02-07
Last Posted Date
2014-02-07
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
2400
Registration Number
NCT02057302

Danhong Injection in the Treatment of Unstable Angina Pectoris

Phase 4
Completed
Conditions
Unstable Angina Pectoris
Interventions
Drug: Danhong injection
Other: Standard medical care
Drug: Placebo
First Posted Date
2013-12-10
Last Posted Date
2017-12-02
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
160
Registration Number
NCT02007187
Locations
🇨🇳

Zhengzhou No.7 People's Hospital, Zhengzhou, Henan, China

🇨🇳

Xuanwu Hospital, Beijing, Beijing, China

🇨🇳

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, Beijing, China

and more 6 locations

Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy

Not Applicable
Conditions
Epilepsy
Interventions
Device: ear vagus nerve stimulator
First Posted Date
2013-12-09
Last Posted Date
2015-02-13
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
120
Registration Number
NCT02004340
Locations
🇨🇳

Wei He, Beijing, China

Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

Early Phase 1
Completed
Conditions
Hypertension, Resistant to Conventional Therapy
Primary Hypertension
Interventions
Drug: Herbs
Drug: Antihypertensive drugs
First Posted Date
2013-07-22
Last Posted Date
2016-09-07
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
192
Registration Number
NCT01904695
Locations
🇨🇳

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, Beijing, China

A Registry Study on Reduning(a Chinese Medicine Injection)Used in Hospitals in China

Conditions
Upper Respiratory Tract Infection;
Acute Tracheobronchitis
First Posted Date
2013-04-05
Last Posted Date
2013-04-05
Lead Sponsor
China Academy of Chinese Medical Sciences
Target Recruit Count
3000
Registration Number
NCT01824719
Locations
🇨🇳

Institute of Basic Research in Clinical Medicine, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath